Managing adult patients with infectious diseases in emergency departments: international ID-IRI study

dc.authorid0000-0002-5650-6911
dc.authorid0000-0002-3613-0523
dc.authorid0000-0002-3631-893X
dc.authorid0000-0002-3778-7877
dc.authorid0000-0002-7290-8945
dc.authorid0000-0003-2543-9987
dc.authorid0000-0001-8695-7118
dc.contributor.authorErdem, Hakan
dc.contributor.authorHargreaves, Sally
dc.contributor.authorAnkaralı, Handan
dc.contributor.authorCaşkurlu, Hülya
dc.contributor.authorCeviker, Sevil Alkan
dc.contributor.authorBahar-Kacmaz, Asiye
dc.contributor.authorMeric-Koc, Meliha
dc.date.accessioned2025-05-10T19:45:18Z
dc.date.issued2021
dc.departmentİMÜ, Fakülteler, Temel Tıp Bilimleri Bölümü
dc.description.abstractWe aimed to explore factors for optimizing antimicrobial treatment in emergency departments. A single-day point prevalence survey was conducted on January 18, 2020, in 53 referral/tertiary hospitals in 22 countries. 1957 (17%) of 11557 patients presenting to EDs had infections. The mean qSOFA score was 0.37 +/- 0.74. Sepsis (qSOFA >= 2) was recorded in 218 (11.1%) patients. The mean qSOFA score was significantly higher in low-middle (1.48 +/- 0.963) compared to upper-middle (0.17 +/- 0.482) and high-income (0.36 +/- 0.714) countries ( P < 0.001). Eight (3.7%) patients with sepsis were treated as outpatients. The most common diagnoses were upper-respiratory (n = 877, 43.3%), lower-respiratory (n = 316, 16.1%), and lower-urinary (n = 201, 10.3%) infections. 1085 (55.4%) patients received antibiotics. The most-commonly used antibiotics were beta-lactam (BL) and BL inhibitors (n = 307, 15.7%), third-generation cephalosporins (n = 251, 12.8%), and quinolones (n = 204, 10.5%). Irrational antibiotic use and inappropriate hospitalization decisions seemed possible. Patients were more septic in countries with limited resources. Hence, a better organizational scheme is required.
dc.identifier.doi10.1080/1120009X.2020.1863696
dc.identifier.endpage318
dc.identifier.issn1120-009X
dc.identifier.issn1973-9478
dc.identifier.issue5
dc.identifier.pmid33734040
dc.identifier.scopus2-s2.0-85102939065
dc.identifier.scopusqualityQ3
dc.identifier.startpage302
dc.identifier.urihttps://doi.org/10.1080/1120009X.2020.1863696
dc.identifier.urihttps://hdl.handle.net/20.500.14730/11198
dc.identifier.volume33
dc.identifier.wosWOS:000630391700001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofJournal of Chemotherapy
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectEmergency
dc.subjectinfection
dc.subjectsepsis
dc.subjecttreatment
dc.subjectantibiotic
dc.subjectelderly
dc.titleManaging adult patients with infectious diseases in emergency departments: international ID-IRI study
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
11198.pdf
Boyut:
943.02 KB
Biçim:
Adobe Portable Document Format